Bibliographic Details
| Title: |
Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074. |
| Authors: |
Uhm JH; Division of Neuro-Oncology, Department of Neurology, Mayo Clinic Rochester, Rochester, MN 55905, USA. uhm.joon@mayo.edu, Ballman KV, Wu W, Giannini C, Krauss JC, Buckner JC, James CD, Scheithauer BW, Behrens RJ, Flynn PJ, Schaefer PL, Dakhill SR, Jaeckle KA |
| Source: |
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2011 Jun 01; Vol. 80 (2), pp. 347-53. Date of Electronic Publication: 2010 May 25. |
| Publication Type: |
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
